How many drugs treat Acute gonococcal cervicitis?

Drug Landscape tracks 10 marketed treatments for Acute gonococcal cervicitis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/acute-gonococcal-cervicitis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Acute gonococcal cervicitis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute gonococcal cervicitis (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Acute gonococcal cervicitis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Zymar	GATIFLOXACIN	Allergan		DNA gyrase, DNA gyrase, DNA gyrase subunit A	2003-01-01
Tomefloxacin	GREPAFLOXACIN	Otsuka	grepafloxacin	Potassium voltage-gated channel subfamily H member 2	1997-01-01
ALATROFLOXACIN	ALATROFLOXACIN	Pfizer	alatrofloxacin		1997-01-01
Zithromax	azithromycin	Pfizer Inc.	Macrolide antibiotic (azalide)	Canalicular multispecific organic anion transporter 1, Taste receptor type 2 member 4, Motilin receptor	1991-11-01
Cipro	ciprofloxacin	Bayer AG	Fluoroquinolone antibiotic	DNA topoisomerase II, DNA gyrase subunit A, DNA gyrase subunit A	1987-10-22
Ceftin	CEFUROXIME AXETIL	GSK	Cephalosporin Antibacterial		1987-01-01
Rocephin	ceftriaxone	Generic (originally Roche)	Cephalosporin antibiotic (third-generation)	Alpha-synuclein, D-amino-acid oxidase, Penicillin-binding protein 1A	1984-12-21
Zinacef	CEFUROXIME	GSK	Cephalosporin Antibacterial	Carbonic anhydrase 2	1983-01-01
Minocycline Hydrochloride	MINOCYCLINE	Rempex	Tetracycline-class Drug		1971-01-01
Vibramycin	doxycycline	Generic (originally Pfizer)	Tetracycline antibiotic	72 kDa type IV collagenase, Stromelysin-1, Collagenase 3	1967-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 10 drugs in Acute gonococcal cervicitis
Pfizer · 3 drugs in Acute gonococcal cervicitis
GSK · 2 drugs in Acute gonococcal cervicitis
Astellas Pharma · 1 drug in Acute gonococcal cervicitis
Bayer AG · 1 drug in Acute gonococcal cervicitis
Bristol-Myers Squibb · 1 drug in Acute gonococcal cervicitis
Bulovka Hospital · 1 drug in Acute gonococcal cervicitis
Centre Hospitalier Universitaire Vaudois · 1 drug in Acute gonococcal cervicitis
Generic (originally Abbott/Lilly) · 1 drug in Acute gonococcal cervicitis
Generic (originally Pfizer) · 1 drug in Acute gonococcal cervicitis
Generic (originally Roche) · 1 drug in Acute gonococcal cervicitis
Johnson And Johnson · 1 drug in Acute gonococcal cervicitis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Acute gonococcal cervicitis:

Cite this brief

Drug Landscape (2026). Acute gonococcal cervicitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/acute-gonococcal-cervicitis. Accessed 2026-06-10.

Acute gonococcal cervicitis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing